Pearce Samantha 4
4 · Jazz Pharmaceuticals plc · Filed Jan 19, 2024
Insider Transaction Report
Form 4
Pearce Samantha
EVP, Chief Commercial Officer
Transactions
- Award
Ordinary Shares
2024-01-17+2,210→ 15,369 total - Tax Payment
Ordinary Shares
2024-01-17$119.13/sh−1,038$123,657→ 14,331 total
Footnotes (2)
- [F1]Represents ordinary shares of Jazz Pharamceuticals that will be delivered pursuant to the terms of performance share awards made to the reporting person on May 5, 2021. The performance-based vesting requirements applicable to such awards were satisfied on January 17, 2024, which represents the date on which the level of performance attained was certified.
- [F2]Shares to be withheld from the vesting and distribution of performance award shares to satisfy the reporting person's tax obligations.